Investment
Features
FeesSafety
Academy
More
Pluang+

Fed's inflation data shows persistent price pressures, signaling likely rate hikes ahead.

Market News
29 Sep 2026
CNBC
View Source
Bearish
Fed's inflation data shows persistent price pressures, signaling likely rate hikes ahead.

The Federal Reserve's preferred inflation gauge, the personal consumption expenditures price index, is expected to show steady inflation above the 2% target, with year-over-year increases around 3.7% for all items and 3.3% for core items. This persistent inflation, combined with continued consumer spending despite rising prices, suggests the Fed is unlikely to pause its monetary tightening. Key Fed officials have indicated another rate hike is probable before year-end to address ongoing inflation pressures. Market expectations align with this outlook, pricing in further rate increases in the coming months.

The Fed's inflation gauge is the story's subject, with Pluang data providing market context. For readers following Financials, here is Pluang's market snapshot as of Sep 30, 2026 01:11 WIB: Of 85 priced US Financials stocks, 22 rose and 60 fell. Notable moves include TCPC at USD 4.07 (+2.26%), GPN at USD 82.99 (-2.02%), and AFRM at USD 68.55 (+1.99%) with 100% buy order activity and a typical hold time of 21 days.

More News

Micron projects record $51.33B revenue driven by AI memory demand, with EPS soaring to $31.72 this quarter.

Micron projects record $51.33B revenue driven by AI memory demand, with EPS soaring to $31.72 this quarter.

Micron Technology is set to report record quarterly revenue of up to $51.33 billion, fueled by strong demand for high-bandwidth memory in the AI market. Earnings per share are expected to jump significantly to around $31.72, compared to $3.03 last ye...

Company Fundamentals
Bullish
18 minutes ago
Sangoma beats EPS estimates but misses revenue; acquisition deal boosts shares 35%.

Sangoma beats EPS estimates but misses revenue; acquisition deal boosts shares 35%.

Sangoma Technologies reported a smaller-than-expected loss with an EPS of -$0.08, beating analyst estimates of -$2.19, though its revenue of $48.55 million slightly missed expectations. Despite ongoing profitability challenges reflected in a negative...

Company Fundamentals
Bullish
2 hours ago
Iovance Biotherapeutics raises 2026 revenue forecast with strong Q2 sales and analyst optimism.

Iovance Biotherapeutics raises 2026 revenue forecast with strong Q2 sales and analyst optimism.

Iovance Biotherapeutics has increased its full-year 2026 revenue guidance to $410-$420 million, reflecting nearly 60% growth driven by strong U.S. demand for its cancer therapy Amtagvi, which generated $91 million in Q2 sales. Analyst Joseph Pantgini...

Analyst Insights
Bullish
3 hours ago
uniQure shares drop 37% after mixed results in Huntington's gene therapy trial

uniQure shares drop 37% after mixed results in Huntington's gene therapy trial

uniQure's stock fell sharply by 37% following a four-year update on its AMT-130 gene therapy for Huntington's disease, which showed reduced effectiveness from 80% at three years to 44% at four years, failing to reach statistical significance. Despite...

Market News
Bearish
3 hours ago
First Financial Bank to open new full-service branch in Bee Cave, Texas, expanding in Austin area.

First Financial Bank to open new full-service branch in Bee Cave, Texas, expanding in Austin area.

First Financial Bank, a subsidiary of First Financial Bankshares, Inc., announced it will open a new full-service branch in Bee Cave, Texas, in late October. This marks the bank's 81st location and strengthens its presence in Central Texas and the gr...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App